MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR)*
Organization & Developments: X4 Pharmaceuticals
Parents
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR)*
Children
*Biopharmaceutical company focused on the research, development and commercialization of therapeutics for the treatment of rare diseases with an initial focus on the treatment of people with immune system dysfunction
2022: X4 joins handful of biotechs sending staff out the door in 'strategic prioritization'
2022: X4 Pharmaceuticals (XFOR) Investor Presentation - Slideshow_seekingalpha.com
2023: X4: Dip Following Mixed Results In Chronic Neutropenia Indication Worth Buying
2024: X4 Pharmaceuticals: PDUFA Excitement Ahead
Jumps
Finance & Acquisition: X4 Pharmaceuticals
Key People: X4 Pharmaceuticals